Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin as adjunct to milrinone for neonatal pulmonary hypertension
NCT06685679Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- May 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in persistent pulmonary hypertension of the newborn (PPHN), sponsored by Ain Shams University. Started May 2024; status: completed.
02
Drugs
melatonin
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NCT06685679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06685679.